Role of uncoupling protein-2 in alcoholic cardiomyopathy

解偶联蛋白2在酒精性心肌病中的作用

基本信息

  • 批准号:
    7083567
  • 负责人:
  • 金额:
    $ 4.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alcohol is a major public health concern in the United States due to the various well-documented pathological conditions associated with its use and abuse. Alcohol-induced heart disease is responsible for significant amount of morbidity and mortality in alcoholics, however, the understanding of many of the underlying molecular mechanisms remains elusive. The goal of this study is to test the hypotheses that 1) uncoupling protein-2 (UCP2) expression and activity has direct consequences which contribute to decreased myocardial contractility and the development of heart failure in alcoholic cardiomyopathy (ACM), 2) oxidative damage due to generation of excess reactive oxygen species (ROS) contributes to disease onset and progression, and UCP2 expression is induced in an effort to dampen ROS generation and to prevent further oxidative damage, and 3) this adaptive change leading to UCP2 expression leads to decreased ATP production, thus hindering various ATP-dependent cellular processes and ultimately contributing to compromised myocardial function and heart failure.
描述(由申请人提供):由于与使用和滥用相关的各种有据可查的病理状况,酒精是美国的主要公共卫生问题。酒精引起的心脏病是酗酒者的大量发病率和死亡率的原因,但是,对许多基本分子机制的理解仍然难以捉摸。这项研究的目的是测试假设,即1)解开蛋白-2(UCP2)表达和活性具有直接的后果,导致心肌收缩力降低以及酒精性心肌病(ACM)的心力衰竭的发展,2)氧化性损害,导致过量的反应性氧气(ROS)的发挥作用和势力的疾病构成势力和UC 2的疾病,UC2的努力和UC2的努力构成了2,UC2的努力是UC的2.防止进一步的氧化损伤,3)这种适应性变化导致UCP2表达导致ATP产生降低,从而阻碍了各种ATP依赖性细胞过程,并最终导致了损害心肌功能和心力衰竭。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jay D Turner其他文献

P123. Determinants of cost-effectiveness in minimally invasive surgery for adult spinal deformity correction
  • DOI:
    10.1016/j.spinee.2024.06.145
  • 发表时间:
    2024-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nima Alan;Jamshaid Mir;Alexander Antonios Theologis;Juan S. Uribe;Jay D Turner;Richard G Fessler;David O Okonkwo;Adam Kanter;Paul Park;Michael Y. Wang;Neel Anand;Pierce D Nunley;Robert K. Eastlack;Gregory M. Mundis;Vivian Le;Shay Bess;Peter Gust Passias; International Spine Study Group
  • 通讯作者:
    International Spine Study Group
What predicts the best 24-month outcomes following surgery for cervical spondylotic myelopathy? A QOD prospective registry study.
什么可以预测脊髓型颈椎病手术后 24 个月的最佳结果?
  • DOI:
    10.3171/2023.11.spine23222
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Andrew K Chan;Christine Park;Christopher I Shaffrey;Oren N. Gottfried;Khoi D. Than;E. Bisson;M. Bydon;A. Asher;D. Coric;E. Potts;Kevin T. Foley;Michael Y. Wang;Kai;M. Virk;J. Knightly;Scott A. Meyer;Paul Park;C. Upadhyaya;M. Shaffrey;Avery L. Buchholz;L. Tumialán;Jay D Turner;Giorgos D. Michalopoulos;Brandon A Sherrod;N. Agarwal;Dean Chou;R. Haid;P. Mummaneni
  • 通讯作者:
    P. Mummaneni
Does the number of social factors affect long-term patient-reported outcomes and satisfaction in those with cervical myelopathy? A QOD study.
社会因素的数量是否会影响脊髓型颈椎病患者的长期患者报告结果和满意度?
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Christine Park;Christopher I Shaffrey;Khoi D. Than;E. Bisson;Brandon A Sherrod;A. Asher;D. Coric;E. Potts;Kevin T. Foley;Michael Y. Wang;Kai;M. Virk;J. Knightly;Scott A. Meyer;Paul Park;C. Upadhyaya;M. Shaffrey;Avery L. Buchholz;L. Tumialán;Jay D Turner;N. Agarwal;Andrew K Chan;Dean Chou;Nauman S Chaudhry;R. Haid;P. Mummaneni;Georgios D Michalopoulos;M. Bydon;Oren N. Gottfried
  • 通讯作者:
    Oren N. Gottfried
P10. Biomechanics of the intact occiput-C2 spine: a retrospective analysis of 181 cervical motion segments
  • DOI:
    10.1016/j.spinee.2024.06.031
  • 发表时间:
    2024-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Temesgen Assefa;Anna G.U. Sawa;S. Harrison Farber;Jay D Turner;Brian Kelly
  • 通讯作者:
    Brian Kelly
P99. Are two-year reoperation rates different for circumferential minimally invasive surgery (cMIS) vs open ASD surgery? A propensity matched cohort study using a prospective ASD database
  • DOI:
    10.1016/j.spinee.2022.06.356
  • 发表时间:
    2022-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Saman Shabani;Andrew Kai-Hong Chan;Nitin Agarwal;Vivian Le;Alexander Aabedi;Paul Park;Juan S. Uribe;Jay D Turner;Robert K. Eastlack;Richard G Fessler;Khoi D. Than;Kai-Ming G. Fu;Michael Y. Wang;Adam S. Kanter;David O Okonkwo;Pierce D Nunley;Neel Anand;Peter G Passias;Shay Bess;Christopher I. Shaffrey
  • 通讯作者:
    Christopher I. Shaffrey

Jay D Turner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jay D Turner', 18)}}的其他基金

Role of uncoupling protein-2 in alcoholic cardiomyopathy
解偶联蛋白2在酒精性心肌病中的作用
  • 批准号:
    7247256
  • 财政年份:
    2004
  • 资助金额:
    $ 4.03万
  • 项目类别:
Role of uncoupling protein-2 in alcoholic cardiomyopathy
解偶联蛋白2在酒精性心肌病中的作用
  • 批准号:
    6791746
  • 财政年份:
    2004
  • 资助金额:
    $ 4.03万
  • 项目类别:
Role of uncoupling protein-2 in alcoholic cardiomyopathy
解偶联蛋白2在酒精性心肌病中的作用
  • 批准号:
    6913699
  • 财政年份:
    2004
  • 资助金额:
    $ 4.03万
  • 项目类别:

相似海外基金

Synaptic Mechanisms underlying sex-differences in alcohol use disorder
酒精使用障碍性别差异背后的突触机制
  • 批准号:
    10604321
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
Alpha2 adrenergic receptors as a target for alcohol addiction
α2 肾上腺素能受体作为酒精成瘾的靶点
  • 批准号:
    10392187
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
Alpha2 adrenergic receptors as a target for alcohol addiction
α2 肾上腺素能受体作为酒精成瘾的靶点
  • 批准号:
    10557791
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
Novel role of beta2-adrenergic receptor signaling in vBNST CRF-mediated stress-induced ethanol intake
β2-肾上腺素能受体信号在 vBNST CRF 介导的应激诱导的乙醇摄入中的新作用
  • 批准号:
    10226256
  • 财政年份:
    2019
  • 资助金额:
    $ 4.03万
  • 项目类别:
Novel role of beta2-adrenergic receptor signaling in vBNST CRF-mediated stress-induced ethanol intake
β2-肾上腺素能受体信号在 vBNST CRF 介导的应激诱导的乙醇摄入中的新作用
  • 批准号:
    10005021
  • 财政年份:
    2019
  • 资助金额:
    $ 4.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了